COVID-19出院患者“复阳”情况及原因分析

doi:10.12183/j.scjpm.2020.0514

摘要/Abstract

摘要： 国内新型冠状病毒肺炎（COVID-19）疫情虽已得到基本控制,但有部分患者在出院后康复隔离观察期核酸检测再次呈阳性,即出现“复阳”现象,具体原因尚不明确。可能由新型冠状病毒（SARS-CoV-2）的病原学特点决定,也可能与病毒入侵后产生的机体免疫反应、患者的病程和病情以及样本采样部位、处理方式、检测等一系列因素相关,因此对出院患者的核酸检测仍需重视。本文就COVID-19出院患者核酸检测复查阳性情况及其可能存在的原因进行综述,为后续复阳患者的防控工作和科学研究提供理论支持。

关键词: 新型冠状病毒肺炎, 新型冠状病毒, 核酸检测复阳, 原因分析

中图分类号:

R183.3

曾金彩, 黄淑芬, 邓小玲, 梁伟坚, 郝元涛. COVID-19出院患者“复阳”情况及原因分析[J]. 华南预防医学, 2020, 46(5): 514-518.

参考文献

[1] 国家卫生健康委员会.截至4月30日24时新型冠状病毒肺炎疫情最新情况[EB/OL]. (2020-05-01)[2020-05-05].http://www.nhc.gov.cn/xcs/yqtb/202005/11f6b5e28be64f28b5b84 eed2984ed60.shtml.
[2] Lan L, Xu D, Ye G, et al.Positive RT-PCR test results in patients recovered from COVID-19[J]. JAMA,2020,323(15):1502-1503.
[3] Chen D, Xu W, Lei Z, et al.Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report[J]. Int J Infect Dis,2020,93:297-299.
[4] An J, Liao X, Xiao T, et al.Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test[J/OL]. medRxiv,2020.DOI:10.1101/2020.03.26.20044222.
[5] 卓丽,魏芳芳,周建群,等.新型冠状病毒肺炎患者34例转归影响因素[J].实用医学杂志,2020,36(14):1861-1865.
[6] 李泉,张浩,邓斯予,等.COVID-19恢复期病毒核酸检测复阳与阴性患者淋巴细胞亚群及形态学特征比较研究[J/OL].重庆医学:1-6(2020-04-03)[2020-05-15].http://kns.cnki.net/kcms/detail/50.1097.R.20200402.1901.010.html.
[7] 李桂伟,李凯霖,郭梦圆,等.辨证治疗新型冠状病毒肺炎出院后核酸复检阳性2例报道[J].天津中医药,2020,37(8):854-857.
[8] 李游江, 胡瑛瑛, 张晓东, 等.七例2019冠状病毒病(COVID-19)普通型患者出院后病毒核酸随访结果[J].浙江大学学报(医学版),2020,49(2):270-274.
[9] 冯协和, 李志浩, 柯昌虎, 等.新型冠状病毒肺炎患者治愈后再入院病情分析探讨[J].中华医院感染学杂志,2020,30(11):1630-1636.
[10] 罗纯,温学良,谭颖,等.广州地区新型冠状病毒肺炎出院病例核酸再次阳性的临床特征[J].广东医学,2020,41(13):1297-1301.
[11] Zhang B, Liu S, Dong Y, et al.Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19)[J].J Infect,2020,81(2):e49-e52.
[12] Zhang T, Cui X, Zhao X, et al.Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia[J]. J Med Virol,2020,92(7):909-914.
[13] Zhang J, Yan K, Ye H, et al.SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge[J]. Int J Infect Dis,2020, 97:212-214.
[14] Peeri NC, Shrestha N, Rahman MS, et al.The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned?[J]. Int J Epidemiol,2020,49(3):717-726.
[15] Liu J, Xiao Y, Shen Y, et al.Detection of SARS-CoV-2 by RT-PCR in anal from patients who have recovered from coronavirus disease 2019[J/OL].J Med Virol,2020.DOI:10.1002/jmv.25875.
[16] 熊成龙, 蒋露芳, 姜庆五. β-冠状病毒引起人类疾病的流行与控制[J].上海预防医学,2020,32(1):58-66.
[17] Lu R, Zhao X, Li J, et al.Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding[J]. Lancet,2020,395(10224):565-574.
[18] 袁园. MERS-CoV和SARS-CoV刺突蛋白及其与受体相互作用的结构与功能研究[D]. 合肥:中国科学技术大学,2017.
[19] Wrapp D, Wang N, Corbett KS, et al.Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J]. Science,2020,367(6483):1260-1263.
[20] Wang Y, Wang Y, Chen Y, et al.Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures[J]. J Med Virol,2020,92(6):568-576.
[21] Wölfel R, Corman VM, Guggemos W, et al.Virological assessment of hospitalized patients with COVID-2019[J]. Nature,2020,581(7809):465-469.
[22] Cao X.COVID-19: Immunopathology and its implications for therapy[J]. Nat Rev Immunol,2020,20(5):269-270.
[23] Tan M, Liu Y, Zhou R, et al.Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China[J]. Immunology, 2020, 160(3): 261-268.
[24] Chen X, Ling J, Mo P, et al.Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients[J/OL]. medRxiv,2020.DOI: 10.1101/2020.03.12.20034736.
[25] Liu J, Zheng X, Tong Q, et al.Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV[J]. J Med Virol,2020,92(5):491-494.
[26] Zhao J, Yuan Q, Wang H, et al.Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019[J/OL]. Clin Infect Dis,2020.DOI: 10.1093/cid/ciaa344.
[27] Zhang B, Zhou X, Zhu C, et al.Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity[J]. Front Mol Biosci,2020,7:157.
[28] Qin C, Zhou L, Hu Z, et al.Dysregulation of immune response in patients with COVID-19 in Wuhan, China[J]. Clin Infect Dis,2020,71(15):762-768.
[29] 程克斌,魏明,沈虹,等.普通型和重型新型冠状病毒肺炎康复患者463例临床特征分析[J].上海医学,2020,43(4):224-232.
[30] Guo L, Wei D, Zhang X, et al.Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA Score[J]. Front Microbiol,2019,10:2752.
[31] 李萍,李志勇,赵四林,等. 血清2019-nCoV IgM和IgG抗体用于诊断新型冠状病毒肺炎的初探[J].中华检验医学杂志,2020, 43(4):352-357.
[32] Wang B, Wang L, Kong X, et al.Long-term coexistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with antibody response in coronavirus disease 2019 (COVID-19) patients[J]. J Med Virol,2020. DOI:10.1002/jmv.25946.
[33] Corman VM, Albarrak AM, Omrani AS, et al.Viral shedding and antibody response in 37 patients with middle east respiratory syndrome coronavirus infection[J]. Clin Infect Dis, 2016,62(4):477-483.
[34] Alshukairi AN, Khalid I, Ahmed WA, et al.Antibody response and disease severity in healthcare worker MERS survivors[J]. Emerg Infect Dis,2016,22(6):1113-1115.
[35] 闫惠平, 檀玉芬, 庄辉, 等. 严重急性呼吸综合征患者冠状病毒总抗体及N和S蛋白抗体的随访研究[J].中华内科杂志,2006, 54(11):896-899.
[36] 里进,叶光明,陈良君,等.新型冠状病毒核酸检测假阴性结果原因分析及对策[J].中华检验医学杂志,2020,43(3):221-225.
[37] 吴冰珊, 俞婷婷, 黄枝妙, 等.新型冠状病毒肺炎确诊病例粪便样本的病毒核酸检测[J]. 中国人兽共患病学报,2020,36(5):359-361.
[38] 吴建国, 罗建飞, 刘家盛, 等.重型/危重型新型冠状病毒肺炎患者多种生物样本核酸检测结果分析[J].解放军医学院学报,2020,41(3):205-207,211.
[39] Zou L, Ruan F, Huang M, et al.SARS-CoV-2 viral load in upper respiratory specimens of infected patients[J]. N Engl J Med,2020,382(12):1177-1179.
[40] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志,2020,41(2):145-151.
[41] Liu W, Tang F, Fontanet A, et al.Long-term SARS coronavirus excretion from patient cohort, China[J]. Emerg Infect Dis,2004,10(10):1841-1843.
[42] 邹静波,周杨,乔洁,等.关于重庆地区在治疗后的“新冠”病人粪便中发现2019新型冠状病毒核酸阳性的病例报告[J].病毒学报,2020,36(2):165-169.
[43] Wu Y, Guo C, Tang L, et al.Prolonged presence of SARS-CoV-2 viral RNA in faecal samples[J]. Lancet Gastroenterol Hepatol,2020,5(5):434-435.
[44] Yao XH, He ZC, Li TY, et al.Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient[J]. Cell Res,2020,30(6):541-543.
[45] 李振昊, 高小玲, 杨小娟, 等. 新型冠状病毒核酸检测分析[J].检验医学与临床,2020,17(10):1313-1315.
[46] 马雯,张伟宏,马瑛龙,等.不同核酸提取试剂盒在新型冠状病毒核酸检测中的比较研究[J].分子诊断与治疗杂志,2020,12(5):552-556.